Pharsight

Drugs that contain Glycopyrrolate; Indacaterol Maleate

1. Utibron patents expiration

UTIBRON's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6878721 NOVARTIS Beta2-adrenoceptor agonists
Feb, 2025

(9 months from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6521260 NOVARTIS Carrier particles for use in dry powder inhalers
Jan, 2016

(8 years ago)

US6582678 NOVARTIS Carrier particles for use in dry powder inhalers
Apr, 2018

(6 years ago)

US8283362 NOVARTIS Beta-2-adrenoreceptor agonists
Jun, 2020

(3 years ago)

US8067437 NOVARTIS Beta-2-adrenoreceptor agonists
Jun, 2020

(3 years ago)

US8658673 NOVARTIS BETA2-adrenoreceptor agonists
Jun, 2020

(3 years ago)

US8796307 NOVARTIS Beta2-adrenoreceptor agonists
Jun, 2020

(3 years ago)

US7820694 NOVARTIS Beta-2-adrenoreceptor agonists
Jun, 2020

(3 years ago)

US8029768 NOVARTIS Treatment of respiratory diseases
Apr, 2021

(3 years ago)

US7229607 NOVARTIS Treatment of respiratory disease
Apr, 2021

(3 years ago)

US7736670 NOVARTIS Method of making particles for use in a pharmaceutical composition
Jun, 2021

(2 years ago)

US8580306 NOVARTIS Particles for use in a pharmaceutical composition
Jun, 2021

(2 years ago)

US9962338 NOVARTIS Method of making particles for use in a pharmaceutical composition
Jun, 2021

(2 years ago)

US8956661 NOVARTIS Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof
Jun, 2021

(2 years ago)

US8435567 NOVARTIS Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
Jun, 2021

(2 years ago)

US8303991 NOVARTIS Method of making particles for use in a pharmaceutical composition
Jun, 2021

(2 years ago)

US8048451 NOVARTIS Pharmaceutical compositions for inhalation
Jun, 2021

(2 years ago)

US9931304 NOVARTIS Method of making particles for use in a pharmaceutical composition
Jun, 2021

(2 years ago)

US8479730 NOVARTIS Inhaler device
Oct, 2028

(4 years from now)

US8182838 NOVARTIS Dry powder composition comprising co-jet milled particles for pulmonary inhalation
Oct, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Jul 01, 2016
New Product(NP) Oct 29, 2018

NCE-1 date: 02 July, 2015

Market Authorisation Date: 29 October, 2015

Treatment: Long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd)

Dosage: POWDER;INHALATION

More Information on Dosage

UTIBRON family patents

Family Patents